摘要：2025年6月5日，在第54个世界环境日来临之际，重庆博腾制药科技股份有限公司（以下简称“博腾股份”）积极响应全球可持续发展倡议，正式发布2030年环境目标，彰显低碳绿色发展转型决心。
Swipe Left for English News→
2025年6月5日，在第54个世界环境日来临之际，重庆博腾制药科技股份有限公司（以下简称“博腾股份”）积极响应全球可持续发展倡议，正式发布2030年环境目标，彰显低碳绿色发展转型决心。
作为全球制药产业链的参与者，博腾股份始终保持与全球客户及合作伙伴在可持续发展领域的密切合作。2024年，公司参与可持续市场倡议（Sustainable Markets Initiative），开展绿电采购；同时通过安装太阳能光伏发电装置，提升清洁能源覆盖率，推动低碳转型。在研发生产环节，公司以绿色化学理念为指引，通过工艺优化、设备设施改造升级提高能源利用率，主动减少或替代环境有害试剂，并积极开发与运用环境友好型制药工艺和技术，提升资源循环利用率，减少废弃物产生。此外，公司构建“风险识别 - 动态评估 - 分级管控 - 智能检测”的环境管理闭环体系，运用EHS专项审计、物联网监测等手段防控环境风险，全方面落实绿色制造。
本次发布的环境目标涵盖能耗、水资源和废弃物管理三大领域，与今年3月已获SBTi验证的科学碳目标共同构成博腾股份环境可持续发展目标。
博腾股份董事长、总经理居年丰表示：“此次环境目标的发布，彰显博腾股份全面深化ESG治理、加速推进可持续发展工作的决心，同时锚定生态文明共建的全球愿景，以‘让好药更早惠及大众’为价值基石，进一步将绿色发展理念融入我们服务和运营的每一个环节。”
我们的目标
能耗目标：
以2024年为基准年，到2030年，能耗强度（吨标准煤/百万元人民币营收）降低25%。
水资源目标：
以2024年为基准年，到2030年，用水强度（立方米/百万元人民币营收）降低20%。
废弃物管理目标：
保持100%废弃物合规处置；
以2024年为基准年，到2030年，危险废弃物强度（吨/百万元人民币营收）降低10%。
博腾股份成立于2005年，主要为全球药企、生物科技公司、科研机构等提供从临床前研究到药品上市全生命周期所需的小分子药物、多肽与寡核苷酸药物、蛋白与偶联药物以及细胞与基因治疗药物等一站式服务解决方案，研发、生产、运营场地覆盖中国（重庆、上海、四川、江苏、江西、湖北）、美国、斯洛文尼亚、比利时、瑞士和丹麦等地。我们终坚持以客户为中心，致力于为客户提供创新、可靠的全球化、端到端CDMO服务，让好药更早惠及大众。
June 5, 2025, Chongqing — On the 54th World Environment Day, Porton Pharma Solutions Ltd. (Porton) officially announced its 2030 sustainability targets, highlighting its actions in response to the global sustainable development initiative and determination to transition into a greener future.
As a player in the global pharmaceutical supply chain, Porton has been maintaining close collaboration with global clients and partners in sustainability. In 2024, Porton joined the Sustainable Markets Initiative and procured renewable electricity at its operation sites. Porton also has installed solar photovoltaic systems to increase its clean energy coverage, driving a low-carbon transition. In the R&D and manufacturing phases, guided by green chemistry principles, Porton enhances energy efficiency through process optimization and equipment upgrade, actively reduces or substitutes environmentally harmful reagents, and develops eco-friendly processes and technologies to improve resource recycling and minimize waste. Additionally, Porton has established a comprehensive environmental management system encompassing "risk identification - dynamic assessment - tiered control - intelligent monitoring." Through EHS audits and IoT monitoring, Porton effectively manages environmental risks, fully committing to green development.
The sustainability targets cover three major areas: energy consumption, water resources and waste management. Together with the carbon reduction target validated by the SBTi in March, they constitute Porton's comprehensive sustainability objectives.
“The announcement of the sustainability targets demonstrates Porton's commitment to deepening our ESG governance and accelerating sustainable initiatives. Anchored in the global vision of co-building an ecological civilization and our value foundation of 'enabling the public's early access to good medicines,' we are further integrating the principles of green development into every aspect of our services and operations," said Oliver Ju, Chairman and CEO of Porton.
Our targets:
Energy consumption:
25% intensity reduction in energy consumption by 2030 from a 2024 baseline.
Water Resources:
20% intensity reduction in water consumption by 2030 from a 2024 baseline.
Waste Management:
Maintain 100% compliant waste disposal.
10% intensity reduction in hazardous waste by 2030 from a 2024 baseline.
Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products from pre-clinical to commercialization stages.
来源：动态宝
